Dermacyd PH_DETINLYN (Lactic Acid) Tangerine Mix - Compatibility

Sanofi

Status and phase: Completed; Phase 3

Conditions: Hygiene

Treatments: Drug: Dermacyd PH_DETINLYN (Lactic Acid)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00786097

LACAC_L_04305

Details and patient eligibility

About

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd PHDETINLYN Tangerine Mix.None.

Enrollment: 53 patients

Sex: Female

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

• Phototype Skin I,II, III e IV
• Integral skin test in the region;
• Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion;

Exclusion inclusion:

• Lactation or gestation
• Use of Antiinflammatory and/or immunossupression drugs
• Personnel history of atopy;
• History of sensitivity or irritation for topic products;
• Active cutaneous disease;
• Use of new drugs or cosmetics during the study

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Trial design

Primary purpose: Supportive Care

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

53 participants in 1 patient group

1

Experimental group

Description:

Dermacyd PH_DETINLYN (Lactic Acid)

Treatment:

Drug: Dermacyd PH_DETINLYN (Lactic Acid)